Stem-Cell Cheat Sheet

By Kristen Philipkoski
Wired News

02:00 AM Jul, 18, 2006

http://www.wired.com/news/technology/medtech/0,71401-0.html?tw=wn_index_2


The Senate is scheduled to vote Tuesday on a package of three stem-cell 
bills. One of them could force President Bush to hand down his first veto.

Discussions in the Senate on Monday involved many impassioned discussions 
about the moral status of an embryo, some supported by dubious statistics. 
We've updated our Stem Cell FAQ so you can follow along on C-SPAN and call 
bullpucky when you hear it.


What are embryonic stem cells?

Embryonic stem cells make up the inner cell mass of the blastocyst, a body 
of cells that forms in the first few days immediately following 
fertilization. Blastocysts are about the size of a grain of sand and 
typically consist of about 150 cells.


What's so special about these cells?

Most cells can only produce limited copies of the same kind. Embryonic stem 
cells, by contrast, can develop into many different cell types in the body, 
and have a limitless ability to divide and replenish. As a result, 
embryonic stem cells are an ideal research material. Scientists hope they 
can manipulate these cells to one day produce therapies targeting specific 
diseases, and even regrow damaged or destroyed tissues for any part of the 
body.


Have doctors cured anyone using human embryonic stem cells?

The jury is still out. Some researchers, mostly in developing countries, 
have claimed success. But no one has yet published successful results in a 
peer-reviewed medical journal -- a step required for scientific acceptance 
and confirmation.


Why are some people opposed to embryonic stem-cell research?

Extracting embryonic stem cells from the blastocyst destroys the embryo. 
Some religious and other groups believe human life begins at conception, 
and therefore are ethically opposed to embryonic stem-cell research.


Is it currently illegal to conduct embryonic stem-cell research in the 
United States?

No. Existing regulations only restrict the funding activities of the 
National Institutes of Health, or NIH, the organization that allocates 
federal funds for medical research. Under the current rules, the NIH can't 
fund embryonic stem-cell research except with stem-cell lines approved by 
the president. But scientists can use private funding to perform embryonic 
stem-cell research.


What happens Tuesday?

The Senate will vote on three stem-cell bills, all of which are expected to 
pass. Two of those bills are in line with the Bush administration's 
embryonic stem-cell policy. The third is expected to force a showdown and 
face an almost-certain veto.

The Stem Cell Research Enhancement Act (SB471) is the Senate version of 
HR810, a bill approved by the House of Representatives last year that would 
allow government-funded researchers to use surplus embryos produced at 
fertility clinics that would otherwise be discarded. The bill would 
supersede a 2001 executive order from Bush that restricts NIH funding of 
embryonic stem-cell research to embryonic stem-cell lines that were already 
created by that date. However, under an existing law, researchers are 
barred from spending federal money on research that destroys embryos.


Are embryos the only source of stem cells?

No. Stem cells can be found in many mature tissues, including bone marrow, 
blood, the brain, hair follicles, fat, the pancreas and umbilical cords. 
These stem cells are called "adult" stem cells. Researchers have also 
derived stem cells from fetal tissue taken from embryos older than eight 
weeks, usually following abortion or spontaneous miscarriage.


Does anyone object to using adult stem cells?

No. Objections to date have been focused on harvesting embryonic stem cells.


So why don't scientists just use adult stem cells instead?

Doctors have been using adult stem cells, such as the blood-forming type in 
bone marrow (called hematopoietic stem cells), to perform bone-marrow 
transplants for more than 40 years. Similar techniques have since been 
developed for treating leukemia, lymphoma and several inherited blood 
disorders. But scientists believe adult stem cells are not as flexible as 
embryonic stem cells, and hold far less promise for extreme therapies, such 
as rebuilding nerves severed in a spinal cord injury.


Are there any other options?

Maybe. Scientists and ethicists have been working on alternatives for 
obtaining stem cells as powerful as those that come from embryos without 
actually creating or destroying an embryo. Scientists presented several 
proposals to the President's Council on Bioethics in May 2005. One of the 
bills up for vote this week asks the NIH to focus on making these 
alternative methods viable.


=================================================
George Antunes                    Voice (713) 743-3923
Associate Professor               Fax   (713) 743-3927
Political Science                    Internet: antunes at uh dot edu
University of Houston
Houston, TX 77204-3011         



Reply with a "Thank you" if you liked this post.
_____________________________

MEDIANEWS mailing list
[email protected]
To unsubscribe send an email to:
[EMAIL PROTECTED]

Reply via email to